JP2022550452A5 - - Google Patents
Info
- Publication number
- JP2022550452A5 JP2022550452A5 JP2022520386A JP2022520386A JP2022550452A5 JP 2022550452 A5 JP2022550452 A5 JP 2022550452A5 JP 2022520386 A JP2022520386 A JP 2022520386A JP 2022520386 A JP2022520386 A JP 2022520386A JP 2022550452 A5 JP2022550452 A5 JP 2022550452A5
- Authority
- JP
- Japan
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962910998P | 2019-10-04 | 2019-10-04 | |
| US62/910,998 | 2019-10-04 | ||
| PCT/US2020/053758 WO2021067571A1 (en) | 2019-10-04 | 2020-10-01 | Targeted pulmonary delivery compositions and methods using same |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| JP2022550452A JP2022550452A (ja) | 2022-12-01 |
| JP2022550452A5 true JP2022550452A5 (https=) | 2023-10-05 |
| JPWO2021067571A5 JPWO2021067571A5 (https=) | 2023-10-05 |
| JP7692218B2 JP7692218B2 (ja) | 2025-06-13 |
Family
ID=75337530
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022520386A Active JP7692218B2 (ja) | 2019-10-04 | 2020-10-01 | ターゲティングされた肺送達組成物およびそれを使用する方法 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20220332759A1 (https=) |
| EP (1) | EP4041276A4 (https=) |
| JP (1) | JP7692218B2 (https=) |
| AU (1) | AU2020357866A1 (https=) |
| CA (1) | CA3153476A1 (https=) |
| WO (1) | WO2021067571A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20230241203A1 (en) * | 2020-07-06 | 2023-08-03 | Rutgers, The State University Of New Jersey | Enhancing immune responses through targeted antigen expression |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7041814B1 (en) * | 1998-02-18 | 2006-05-09 | Genome Therapeutics Corporation | Nucleic acid and amino acid sequences relating to Enterobacter cloacae for diagnostics and therapeutics |
| US20050036951A1 (en) * | 2003-01-09 | 2005-02-17 | Arizeke Pharmaceuticals, Inc. | Methods of treating lung diseases |
| US7659252B2 (en) * | 2005-09-15 | 2010-02-09 | Novomed Technologies, Inc. (Shanghai) | Transdermal delivery peptides and method of use thereof |
-
2020
- 2020-10-01 WO PCT/US2020/053758 patent/WO2021067571A1/en not_active Ceased
- 2020-10-01 CA CA3153476A patent/CA3153476A1/en active Pending
- 2020-10-01 AU AU2020357866A patent/AU2020357866A1/en active Pending
- 2020-10-01 US US17/765,379 patent/US20220332759A1/en active Pending
- 2020-10-01 JP JP2022520386A patent/JP7692218B2/ja active Active
- 2020-10-01 EP EP20871920.3A patent/EP4041276A4/en active Pending